Literature DB >> 8405030

The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro.

P M Bath1.   

Abstract

The effects of sodium nitroprusside (SNP) and 3-morpholino sydnonimine (SIN-1), isosorbide dinitrate (ISDN) and glyceryl trinitrate (GTN), and molsidomine (the inactive precursur of SIN-1) on monocyte chemotaxis and cyclic GMP (cGMP) concentration were studied. SNP and SIN-1 inhibited monocyte N-formyl-methionyl-leucyl-phenylalanine-stimulated migration and increased cGMP concentrations in a dose-dependent (> 10(-5) mol.l-1) and time-dependent manner. Furthermore, 8-bromo cGMP inhibited monocyte chemotaxis in a dose-dependent fashion. In contrast, ISDN, GTN and molsidomine did not alter monocyte migration or cGMP concentration. These results support earlier observations that nitric oxide inhibits monocyte function in vitro via a cGMP-mediated mechanism. The differential effects of the spontaneous and thiol-dependent NO-donating nitrovasodilators on monocyte function suggests that monocytes, like platelets, are not able to directly metabolise ISDN and GTN. If similar observations can be made in vivo, it is possible that certain nitrovasodilators might be used therapeutically to inhibit monocyte function, for example during atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405030     DOI: 10.1007/bf00315350

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

Review 1.  Organic nitrate esters: clinical use and mechanisms of actions.

Authors:  J Ahlner; R G Andersson; K Torfgård; K L Axelsson
Journal:  Pharmacol Rev       Date:  1991-09       Impact factor: 25.468

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

Review 3.  Atrial natriuretic peptides: receptors and second messengers.

Authors:  S A Waldman; F Murad
Journal:  Bioessays       Date:  1989-01       Impact factor: 4.345

4.  Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay.

Authors:  P M Bath; R F Booth; D G Hassall
Journal:  J Immunol Methods       Date:  1989-03-10       Impact factor: 2.303

5.  Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites.

Authors:  M Nishikawa; M Kanamori; H Hidaka
Journal:  J Pharmacol Exp Ther       Date:  1982-01       Impact factor: 4.030

6.  Endogenous nitric oxide as a modulator of rabbit skeletal muscle microcirculation in vivo.

Authors:  M G Persson; L E Gustafsson; N P Wiklund; P Hedqvist; S Moncada
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

7.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

Authors:  U C Garg; A Hassid
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

8.  Human monocyte characteristics are altered in hypercholesterolaemia.

Authors:  P M Bath; A M Gladwin; J F Martin
Journal:  Atherosclerosis       Date:  1991-10       Impact factor: 5.162

9.  Platelet function studies in coronary heart disease. IX. Increased platelet prostaglandin generation and abnormal platelet sensitivity to prostacyclin and endoperoxide analog in angina pectoris.

Authors:  J Mehta; P Mehta; C R Conti
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

10.  SIN-1 stimulates the production of cyclic GMP but not cyclic AMP in porcine aortic endothelial cells.

Authors:  V B Schini; P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

View more
  23 in total

1.  Exercise and nitric oxide prevent bubble formation: a novel approach to the prevention of decompression sickness?

Authors:  Ulrik Wisløff; Russell S Richardson; Alf O Brubakk
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

2.  Unraveling the links between diabetes, obesity, and cardiovascular disease.

Authors:  Paul L Huang
Journal:  Circ Res       Date:  2005-06-10       Impact factor: 17.367

Review 3.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

4.  Atheroprotective effects of neuronal nitric oxide synthase in apolipoprotein e knockout mice.

Authors:  Peter J Kuhlencordt; Stefanie Hötten; Johannes Schödel; Sebastian Rützel; Kai Hu; Julian Widder; Alexander Marx; Paul L Huang; Georg Ertl
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

Review 5.  Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.

Authors:  Natasha M Rogers; Maryam Sharifi-Sanjani; Gábor Csányi; Patrick J Pagano; Jeffrey S Isenberg
Journal:  Matrix Biol       Date:  2014-01-11       Impact factor: 11.583

6.  Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro.

Authors:  E Sato; K L Simpson; M B Grisham; S Koyama; R A Robbins
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 7.  Endothelial nitric oxide synthase polymorphisms and hypertension.

Authors:  Aroon D Hingorani
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

8.  Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.

Authors:  J Jankowski; M van der Giet; V Jankowski; S Schmidt; M Hemeier; B Mahn; G Giebing; M Tolle; H Luftmann; H Schluter; W Zidek; M Tepel
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

9.  Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice.

Authors:  Peter J Kuhlencordt; P Padmapriya; S Rützel; J Schödel; K Hu; A Schäfer; P L Huang; G Ertl; J Bauersachs
Journal:  Atherosclerosis       Date:  2008-04-06       Impact factor: 5.162

Review 10.  Cardiovascular determinants of life span.

Authors:  Yi Shi; Giovanni G Camici; Thomas F Lüscher
Journal:  Pflugers Arch       Date:  2009-09-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.